UK approves prescription-only melatonin drug for childhood ADHD
Pharmaceutical Technology
OCTOBER 13, 2022
In July 2019, the MHRA held up Colonis for sending a letter to physicians advertising the off-label use of the drug in children and those with renal impairment. On 22 September, the MHRA expanded the label to include the use for sleep-onset insomnia in children with ADHD. The recommended dosage is even smaller in children.
Let's personalize your content